Investing

Jazz Pharmaceuticals : JAZZ

JAZZ

Stock Data

$170.81

$8.38 (5.16%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing and marketing innovative medicines to meet significant unmet medical needs. With a diverse portfolio, Jazz Pharmaceuticals offers treatments for narcolepsy, epilepsy, cancer, and acute leukemia among other serious conditions. Their products include Xywav, Xyrem, Epidiolex, and Zepzelca, addressing issues from sleep disorders to severe forms of epilepsy and cancer. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is committed to improving patients' lives through science, with ongoing research in neurological disorders and oncology.

All Jazz Pharmaceuticals Articles

80 Articles

Lee Jackson | Nov 24, 2025 at 8:20 AM EST

Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More

Pre-Market Stock Futures: The shortened holiday week is here, and the futures are trading higher this morning. Most traders and…

Trey Thoelcke | Feb 2, 2025 at 8:45 AM EST

Insiders Are Scooping Up These 5 Stocks Now

With the earnings-reporting season underway, insider buying has been slow. Yet some return buyers continue to build stakes, including huge new…

Trey Thoelcke | Jan 26, 2025 at 8:45 AM EST

Huge Insider Buy in Entertainment Giant, and More

The number of notable insider purchases has slowed since the beginning of the year. Yet one huge buy in the…

Trey Thoelcke | Jan 19, 2025 at 9:15 AM EST

A Huge Biotech Purchase Highlights New Year’s Insider Buying

Acquisitions by Warren Buffett and other return buyers highlighted recent insider buying. A biotech company also saw some notable insider…

Rich Duprey | Sep 29, 2024 at 11:32 AM EDT

Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped

Enigmatic investing legend Seth Klarman runs the Boston-based Baupost Group hedge fund that has around $27 billion in assets under…

Joshua Rodriguez | Jul 17, 2024 at 9:22 AM EDT

Add These 5 Hot Biotech Stocks In July

Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in…

Lee Jackson | Jun 13, 2023 at 8:51 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Bill, Carnival, Oracle, Palantir, Petrobras, Valvoline, Walmart and More

Tuesday's top analyst upgrades and downgrades included Bill, Carnival, CenterPoint Energy, Editas Medicine, International Paper, Oracle, Palantir Technologies, Petrobras, SentinelOne,…

Lee Jackson | Sep 21, 2022 at 8:51 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: AutoZone, Etsy, Luminar, Nike, Norwegian Cruise, PayPal, Western Digital, Weyerhaeuser and More

Wednesday's top analyst upgrades and downgrades included AutoZone, EOG Resources, Etsy, Huntsman, Luminar Technologies, Nike, Norwegian Cruise Line, PayPal, Pioneer…

Lee Jackson | Jun 15, 2022 at 8:57 AM EDT

Wednesday’s Top Analyst Upgrades and Downgrades: Chesapeake Energy, eBay, Hewlett Packard Enterprise, Oracle, Phillips 66, US Steel and More

Wednesday's top analyst upgrades and downgrades included Accenture, Bridgebio Pharma, Chesapeake Energy, eBay, Hewlett Packard Enterprise, Huntsman, New York Community…

Chris Lange | Apr 6, 2022 at 3:25 PM EDT

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.

Lee Jackson | Nov 22, 2021 at 8:51 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Chevron, Eli Lilly, Halliburton, Home Depot, Microsoft, Robinhood Markets, Southwest Air and More

Monday's top analyst upgrades and downgrades included Adobe, Anheuser-Busch, Baker Hughes, Chevron, Eli Lilly, Halliburton, Home Depot, Intuit, Microsoft, Robinhood…

Lee Jackson | Oct 5, 2021 at 8:55 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Albertsons, Charles Schwab, CyberArk, Deckers Outdoor, Nike, Procter & Gamble, Tesla and More

Tuesday's top analyst upgrades and downgrades included Albertsons, Charles Schwab, Colgate-Palmolive, CyberArk Software, Deckers Outdoor, Dow, Lordstown Motors, Nike, Procter…

Lee Jackson | Sep 23, 2021 at 8:50 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.

Chris Lange | Apr 7, 2021 at 11:45 AM EDT

Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie &…

Lee Jackson | Feb 22, 2021 at 7:54 AM EST

Jefferies Top Growth Stocks to Buy Include 2 Red-Hot Sports Betting Winners

These four Jefferies growth stock picks for more aggressive investors all have significant catalysts to drive growth the rest of…